Skip to content

Needlescopic Versus Transvaginal/Transumbilical Cholecystectomy

Needlescopic Versus Transvaginal/Transumbilical Cholecystectomy: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01685775
Acronym
NATCH
Enrollment
40
Registered
2012-09-14
Start date
2010-02-28
Completion date
2012-12-31
Last updated
2013-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of Gallbladder With or Without Cholecystitis, Laparoscopic Cholecystectomy

Keywords

Gallbladder, cholecystectomy, NOTES, natural orifice transluminal endoscopic surgery, gallstone

Brief summary

Laparoscopic surgery has become the golden standard for the removal of the gallbladder. Recently, developments have been made so that operations can be performed through a natural orifice instead of the abdominal wall, thus minimizing the trauma of a procedure. This study compares the transvaginal/transumbilical cholecystectomy with the laparoscopic operation using 2-3mm instruments in female patients. It also examines the benefits and disadvantages related to postoperative pain, cosmetic aspects, and potential physiological alterations to the transvaginal approach that affect sexual intercourse.

Detailed description

The amount of trauma inflicted, especially in abdominal operations, depends largely on target organ access. Great efforts have been made to minimize access trauma. The further development of laparoscopy led to the miniaturization of surgical instruments and otherwise the use of natural orifices, like the stomach, rectum or vagina. The cholecystectomy is currently performed needlescopicly with 2-3 mm trocars and in transumbilically assisted transvaginal technique. The aim of this randomized study is to compare these two techniques in female patients that are in need of an elective cholecystectomy. The patients will be randomized on a 1:1 ratio into two treatment groups. In the needlescopic group the investigators will use two 2-3 mm working trocars and one 10 mm optic trocar, also to extract the gallbladder. In the transvaginal/transumbilical group the investigators will perform the Zornig technique using a 5 mm trocar in the umbilicus and a 10 mm trocar together with a 5 mm seizing forceps through the posterior vaginal vault. The primary endpoint of this trial is to measure the intensity of pain in motion measured from the day of the operation until postoperative day 2. Four different measurements of pain will be used. Furthermore the investigators examine perioperative complications as security parameters. The trial is supported in part by the German Ministry of Research and Education (CHIR-Net grant, BMBF No. 01-GH-0605).

Interventions

PROCEDURETransvaginal/transumbilical
PROCEDURENeedlescopic with 3 trocars

Sponsors

University of Witten/Herdecke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Gender: Female * Minimum Age: 18 Years * Maximum Age: 80 Years * indication for elective cholecystectomy on account of symptomatic cholecystolithiasis * age \>=18 years and \<=80 years * legal competence

Exclusion criteria

* Acute cholecystitis or locally complicated disease (gallbladder empyema, choledocholithiasis, pancreatitis, etc.) * liver cirrhosis (Child Pugh A, B, C) * severe comorbidity, class IV or V as defined by the American Society for Anesthesiologists (ASA) * intact hymen * acute vaginal infection * lacking visibility of the uterine orifice * endometriosis * malignoma * obesity with a Body Mass Index (BMI) \> 40 kg/m2 * chronic abuse of analgesics or alcohol * neuromuscular disease that could interfere treatment or measures of pain * history of major abdominal surgery with a high risk of intraperitoneal adhesions (minor operations such as an appendectomy, inguinal hernia repair, minor gynaecological surgery, etc. will not be considered

Design outcomes

Primary

MeasureTime frameDescription
Intensity of pain in motionat the operation dayPain Scores on the Visual Analog Scale (0-10)

Secondary

MeasureTime frameDescription
Intraoperative complicationsevaluated at the operation daye.g. bleeding, organ-injury, especially bile-duct-injury
Duration of the operationat the operation day(in minutes)
Surgical handling for the first and second surgeonevaluated at the operation dayon a 1 to 5 scale
Intensity of pain in motionat postoperative day 2in the evening pain Scores on the Visual Analog Scale (0-10)
Cumulative use of analgesics10 days after the surgeryquantity, dose and class of the used drugs
Cosmetic aspects and overall satisfaction with the results of the surgery10 days after operation1 (complete satisfaction) to 5 (complete dissatisfaction) scale from patient's and surgeon's point of view
Quality of lifeon postoperative day 10measured with the Gastrointestinal Quality of Life Index (GIQLI) from Eypasch et al.
Postoperative restrictions of sexual function3 months after surgerywith questions 14-19 of the female sexual function index (FSFI-D)
Morphological consequences of transvaginal accessat the day before the operation, and again 10 to 14 days and 6 months after their surgeryall patients from the transvaginal/transumbilical group will be examined by a gynaecologist
Conversionrateat the operation dayConversion from transvaginal to classical laparoscopic or open technique and from needlescopic to open technique
Number of Participants with Adverse Events as a Measure of Safety and Tolerabilityat 6 monthincluding frequency of reoperation
Return to everyday, work related and free time activities3 months after operationduration of limitations.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026